US Vaccine Panels: Conflict and Recusal Trends
Conexiant
August 18, 2025
Financial conflicts of interest for US vaccine advisory committees have decreased significantly over the past 25 years.
ACIP's reported conflicts of interest dropped from 43% in 2000 to 5% in 2024.
VRBPAC's conflict rates peaked at 27% in the early 2000s but have remained under 4% since 2010.
The most common conflicts involved research support, consulting, and stock holdings, with income-related conflicts below 1% since 2016.
ACIP's decline in reported conflicts was statistically significant, while VRBPAC's decline was not, despite low rates in recent years.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Editor
Affiliations:
Specialties:
Areas of Expertise: